awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39022841-B38B70B2-EFA7-4C11-9613-7B9CBA9722D0
Q39022841-B38B70B2-EFA7-4C11-9613-7B9CBA9722D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39022841-B38B70B2-EFA7-4C11-9613-7B9CBA9722D0
Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies.
P2860
Q39022841-B38B70B2-EFA7-4C11-9613-7B9CBA9722D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39022841-B38B70B2-EFA7-4C11-9613-7B9CBA9722D0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ab008eb736bb67eed76396677132bca20fa1237
P2860
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.